| Literature DB >> 30211075 |
Eric Tzyy Jiann Chong1, Shawn Shi Erh Kuok1, Ping-Chin Lee1.
Abstract
Introduction: Obesity is commonly linked up with several life-threatening diseases. This study aims to investigate the association of fatty acid synthase (FASN) rs4246445, rs2229425, rs2228305, and rs2229422 single nucleotide polymorphisms (SNPs) with the risk of overweight and obesity in the Malaysian population.Entities:
Keywords: Fatty acid synthase; Obesity; Overweight; Single nucleotide polymorphisms
Year: 2017 PMID: 30211075 PMCID: PMC6128978 DOI: 10.15171/bi.2018.18
Source DB: PubMed Journal: Bioimpacts ISSN: 2228-5652
Fig. 1Demographic data of the normal, overweight, and obese groups
|
|
|
|
|
|
| Gender (Male/Female) | 433/261 | 134/89 | 53/60 | 187/149 |
| Age (y) | 23.41±9.81 | 23.34±9.78 | 23.45±9.88 | 26.76±12.63 |
| Height (cm) | 170.25±10.97 | 168.25±11.62 | 159.50±12.71 | 163.88±12.21 |
| Weight (kg) | 62.25±6.80 | 74.00±10.68 | 90.50±19.60* | 82.25±17.07 |
| BMI (kg/m2) | 21.45±1.29 | 26.05±0.73* | 35.30±3.73* | 30.67±5.54* |
| Systolic (mm Hg) | 117.00±7.75 | 125.50±12.45 | 128.50±4.12* | 127.00±8.73 |
| Diastolic (mm Hg) | 75.75±7.80 | 78.25±5.12 | 84.75±3.59 | 81.50±5.37 |
| Pulse (per min) | 72.00±13.44 | 80.75±9.57 | 76.75±5.68 | 78.75±7.59 |
| Haemoglobin (g/L) | 132.27±20.27 | 144.42±17.95 | 150.71±15.97* | 146.74±17.08* |
| RBC (x1012/L) | 4.88±0.60 | 4.96±0.75 | 5.37±0.55 | 5.11±0.70 |
| WBC (x109/L) | 6.49±1.37 | 6.89±1.43 | 7.93±2.11* | 7.27±1.73 |
| Platelets (x109/L) | 280.58±65.45 | 275.58±62.24 | 271.00±50.58 | 273.89±58.13 |
| Glucose (mmol/L) | 5.30±0.56 | 5.17±0.46 | 5.89±2.85 | 5.43±1.72 |
| Cholesterol (mmol/L) | 4.48±0.44 | 4.83±0.87 | 5.73±2.04 | 5.28±1.53 |
| HDL (mmol/L) | 1.54±0.45 | 1.55±0.15 | 1.21±0.35 | 1.38±0.31 |
| LDL (mmol/L) | 2.52±0.71 | 2.98±0.99 | 3.39±0.60 | 3.18±1.03 |
| Triglyceride (mmol/L) | 0.90±0.31 | 0.65±0.15 | 2.44±1.94 | 1.55±1.59 |
NR, normal (BMI < 25.0 kg/m2); OW, overweight (BMI = 25.0-29.9 kg/m2); OB, obese (BMI ≥ 30.0 kg/m2); BMI, body mass index; RBC, red blood count; WBC, white blood count; HDL, high density lipid; LDL, low density lipid.
*Statistically significant when compared to normal (P < 0.05).
Fig. 2Linkage disequlibrium (LD) analysis of FASN polymorphisms in this study
|
|
|
|
|
|
| rs4246445 | 0.986 | 0.789 | 0.590 | |
| rs2229425 | 0.005 | 1.000 | 0.731 | |
| rs2228305 | 0.025 | 0.000 | 0.575 | |
| rs2229422 | 0.139 | 0.007 | 0.002 |
Values in upper diagonal and lower diagonal represented the D’ and r2for the SNP combinations, respectively
Haplotype analysis of FASN polymorphisms in this study
|
|
|
|
|
|
| TCGT | 0.598 | 0.583 | 1.06 (0.88-1.28) | 0.527 |
| TCGC | 0.050 | 0.044 | 1.14 (0.74-1.75) | 0.553 |
| CCGT | 0.199 | 0.208 | 0.95 (0.75-1.19) | 0.655 |
| CCGC | 0.127 | 0.140 | 0.89 (0.68-1.17) | 0.410 |
| CCAT | 0.020 | 0.019 | 1.07 (0.55-2.06) | 0.843 |
OW, overweight; OB, obese.
*As listed in Table 3 based on the physical marker order: rs4246445, rs2229425, rs2228305 and rs2229422.
**All haplotype frequencies less than 0.010 were ignored in the analysis.
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7